EN
On August 27, the Small Molecule Innovative Drugs Yangtze River Delta Primary and Secondary Market Corporate Leaders Closed-door Meeting, co-hosted by Pineclub and Genhouse, was successfully held in Suzhou. At the meeting, Junlin Wang, founder and chairman of UnionClin, delivered a keynote speech titled "Challenges and Solutions in Early Clinical Studies of Innovative Anti-Tumor Drugs".
2017 is called the "First Year of Innovative Drugs" by the pharmaceutical industry in China.
On August 6, the "Innovative Drug Clinical Study Summit Forum", part of the 2022 Shanghai International Biopharmaceutical Industry Week Series of Events, was opened.
Official WeChat
